Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	19,022,727 L.L
J01DH51	AMANAM 500	G	Imipenem - 500mg, Cilastatin - 500mg	500mg	Injectable powder for solution	997,131 L.L
J01CA01	AMPICILLINE PANPHARMA	G	Ampicillin (sodium) - 500mg	500mg	Injectable powder for solution	1,944,540 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
J01CA01	AMPICILLINE PANPHARMA	G	Ampicillin (sodium) - 1g	1g	Injectable powder for solution	2,857,009 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	L.L
J01DD04	AXONE 1G IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	438,093 L.L
J01DD04	AXONE 500MG IM	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	393,746 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 2.5mg/0.5ml	2.5mg/0.5ml	Injectable solution	5,341,774 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	40,075,575 L.L
M05BA08	ACLASTA	B	Zoledronic acid (monohydrate) - 5mg/100ml	5mg/100ml	Injectable solution	21,075,062 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	170,630 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	182,720 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	205,933 L.L
J01GB06	AMICINE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	1,749,683 L.L
J01GB06	AMIKACIN SULPHATE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	372,244 L.L
M01AB05	ALMIRAL	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	415,247 L.L
M01AB15	ALGIKEY	G	Ketorolac trometamine - 30mg/ml	30mg/ml	Injectable solution	873,498 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 0.5%	0.5%	Injectable solution	1,441,943 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 1%	1%	Injectable solution	1,732,213 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 3%	3%	Injectable solution	2,576,146 L.L

...